Dialysis sorbent and regenerative dialysis sorbent system
By using adsorbent compositions composed of neutral zirconium phosphate, acidic zirconium phosphate, alkaline hydrated zirconium oxide and insoluble alkaline earth metal carbonate, the limitations of the sodium and bicarbonate balance management in the adsorption dialysis system are solved, and the limitations of the sodium and bicarbonate balance management in the adsorption dialysis system are achieved. Improve stability and efficiency in dialysate.
Patent Information
- Application Number
- CN202280079559.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2021-11-30
- Filing Date
- 2022-11-29
- Publication Date
- 2024-11-12
AI Technical Summary
The existing adsorption dialysis system has limitations in controlling serum sodium and bicarbonate balance, especially in traditional peritoneal dialysis, where the management mechanism of sodium and bicarbonate is not directly related, resulting in the optimization of sodium control and bicarbonate balance. It is difficult to achieve, and commonly used methods such as the use of sodium bicarbonate or alkaline hydrated zirconia have solubility problems or insufficient buffer capacity, making it difficult to maintain stable pH and bicarbonate concentration during the treatment process.
Adsorbent compositions composed of neutral zirconium phosphate, acidic zirconium phosphate, alkaline hydrated zirconium oxide, insoluble alkaline earth metal carbonate and polymeric ammonium carbonate, and the proportion and structure of these components are adjusted to achieve the Independent management of sodium and bicarbonate concentrations ensures stability and efficiency during treatment.
The adsorbent composition can effectively manage the concentration of sodium and bicarbonate in the dialysate, avoid mutual interference between sodium and bicarbonate balance, improve pH and bicarbonate stability during the treatment process, and reduce the dialysate. The solubility requirements and buffer use enhance the reliability and safety of the treatment.
Smart Images

Figure CN118946409A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a dialysis sorbent and a regenerative dialysis sorbent system, which may be but is not limited to hemodialysis, peritoneal dialysis, liver dialysis, lung dialysis, water purification and regeneration of biological fluids. Background Art
[0002] The listing or discussion of a previously published document in this specification must not necessarily be taken as an admission that the document is part of the state of the art or is common general knowledge.
[0003] Chronic kidney disease (CKD) often results in imbalances in serum bicarbonate and sodium concentrations. Patients often suffer from low bicarbonate and low serum pH in the form of metabolic acidosis, while untreated CKD may lead to dangerously high serum sodium due to accumulation of dietary sodium intake. These imbalances pose a serious risk to the central nervous system and cardiovascular health. Therefore, the fundamental goal of dialysis is to correct serum sodium balance and acid-base balance to maintain blood homeostasis.
[0004] In conventional peritoneal dialysis such as CAPD or APD, sodium is corrected by maintaining a negative concentration gradient between the dialysate (Na 132mmol / L) and the patient's serum sodium concentration (approximately Na 138mmol / L), thereby removing sodium by diffusion from the blood into the dialysate. This concentration gradient is further increased by delivering ultrafiltrate to the peritoneum, where the sodium content is lower and further dilutes the dialysate. Bicarbonate is corrected by maintaining a positive base balance (net transfer of base from the dialysate to the patient's serum) using a high concentration of lactate ions in the dialysate (Lac 40mmol / L), which diffuse into the patient's blood and are metabolized to bicarbonate by the liver. Therefore, in conventional peritoneal dialysis, sodium and bicarbonate are managed by different mechanisms that do not directly affect each other.
[0005] In contemporary adsorption dialysis systems consisting of urease, zirconium phosphate (ZP), and hydrous zirconium oxide (HZO), there is a direct correlation with the control of bicarbonate and sodium, while simultaneously optimizing Na + and HCO3 - There are limitations in terms of equilibrium. The primary method for controlling sodium in adsorptive dialysis is to remove sodium by ion exchange with hydrogen-loaded ZP (ZP-H):
[0006] ZP-H+Na + →ZP-Na+H +
[0007] However, this ion exchange process only occurs readily in the presence of a base, such as bicarbonate ions:
[0008] ZP-H+HCO3 - +Na+ →ZP-Na+H2O+CO2
[0009] Depending on the overall pH of the dialysate, CO2 may be lost to the atmosphere and result in a net loss of base in the dialysate. While using only acidic hydrogen-loaded ZPs may be suitable for sodium control and removal of other undesirable cations such as ammonium, the subsequent loss of bicarbonate and the resulting low pH will result in an overall worse bicarbonate balance. Figure 1 The relationship between the mole fraction of aqueous carbonate solution, bicarbonate solution and carbonate solution and pH is shown, and Figure 2 Shown is the relationship between the mole fraction of aqueous ammonium solution and ammonia solution and pH.
[0010] The effects of low pH and low bicarbonate are often balanced by adding basic salts such as sodium bicarbonate to the adsorbent and / or using basic anion exchangers such as OH-loaded hydrous zirconium oxide.
[0011] A limitation of the sodium bicarbonate approach is that this salt is readily soluble in aqueous dialysate, thus resulting in a dramatic increase in dialysate sodium and pH at the start of treatment. In this case, the direct addition of a soluble sodium salt is counterproductive to sodium control. This is because in peritoneal dialysis, a hemodialysate concentration gradient is required in order to remove sodium from the patient. Furthermore, this approach does not allow for a sustained increase in pH during treatment, which is desirable from the perspective of patient bicarbonate, since bicarbonate stability is pH dependent as previously discussed.
[0012] The use of alkaline HZO has certain advantages in this regard, as it helps neutralize the acidic dialysate and removes phosphate leached from the ZP-H:
[0013] HZO-OH+H + +X - →HZO-X+H2O (pH<<7, X=Cl, PO4, F)
[0014] However, the amount of HZO required for use as a buffer is not trivial and significantly affects the size and weight of the sorbent cartridge. Furthermore, the reaction rate between HZO and H is fast, so this buffering capacity is easily exhausted, meaning that pH and bicarbonate concentrations are maintained only at the beginning of treatment.
[0015] Current sodium control methods mean that Na + Removal of HCO3 - Excess HCO3 - Removal of sodium bicarbonate can lead to metabolic acidosis, which can cause many unhealthy symptoms and harm to the patient. In current practice, there are other solutions to metabolic acidosis that can be used as adjunctive treatments, such as oral sodium bicarbonate tablets, but this solution is confounded by the same problem;+ Added back into the blood system. Therefore, there is a need for an improved method of bicarbonate management, particularly for use in adsorption dialysis, as a suitable alternative to sodium bicarbonate and alkaline HZO. Summary of the invention
[0016] Disclosed herein is a sorbent composition consisting of varying percentages of neutral zirconium phosphate (NZP), acidic zirconium phosphate (AZP), basic hydrous zirconium oxide (NaHZO), and substantially insoluble salts of CaCO3 and Ca(OH)2. This surprisingly solves some or all of the above problems.
[0017] Various aspects and embodiments of the invention are provided in the following numbered clauses.
[0018] 1. A material for adsorption dialysis, comprising:
[0019] Acidic and / or neutral cation exchange particles;
[0020] Basic anion exchange particles;
[0021] One or more of alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates.
[0022] 2. The material according to clause 1, wherein the material further comprises one or both of Ca(OH)2 and Mg(OH)2.
[0023] 3. A material according to clause 1 or clause 2, wherein the acidic and / or neutral cation exchange particles are acidic and / or neutral water-insoluble metal phosphates, optionally wherein the metal is selected from one or more of titanium, zirconium and hafnium.
[0024] 4. The material of clause 3, wherein the metal is zirconium.
[0025] 5. A material according to any of the preceding clauses, wherein the basic anion exchange particles comprise amorphous and partially hydrated, water-insoluble metal oxides: hydroxide ions; and / or carbonate ions; and / or acetate ions; and / or anti-lactate ion forms, wherein the metal is selected from one or more of titanium, zirconium and hafnium, optionally wherein the anion exchange particles are basic hydrated zirconium oxide.
[0026] 6. A material according to any of the preceding clauses, wherein:
[0027] (a) the water-insoluble alkaline earth metal carbonate is selected from one or more of CaCO3 and MgCO3; and / or
[0028] (b) the alkali metal carbonate is K2CO3; and / or
[0029] (c) The water-insoluble polymeric ammonium carbonate is selected from one or more of sevelamer carbonate, polymer-bonded tetraalkylammonium carbonate and 3-(trialkylammonium)alkyl (eg propyl) functionalized silica carbonate.
[0030] 7. A material according to any one of the preceding clauses, wherein the material comprises:
[0031] 30 wt % to 79 wt % of acidic and / or neutral cation exchange particles;
[0032] 20 wt % to 65 wt % of basic anion exchange particles;
[0033] one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates in an amount of 0.1 wt % to 10 wt % in total;
[0034] One or both of Ca(OH)2 and Mg(OH)2 in a total amount of 0wt% to 5wt%.
[0035] 8. Material according to clause 7, wherein the material comprises:
[0036] 31 wt % to 75 wt % of acidic and / or neutral cation exchange particles;
[0037] 23 wt % to 63 wt % basic anion exchange particles;
[0038] one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates in an amount of 0.1 wt% to 5 wt% in total;
[0039] One or both of Ca(OH)2 and Mg(OH)2 in a total amount of 0wt% to 4wt%.
[0040] 9. Material according to clause 7 or clause 8, wherein the material comprises:
[0041] 50 wt % to 64 wt % of acidic and / or neutral cation exchange particles;
[0042] 35 wt % to 45 wt % of basic anion exchange particles;
[0043] One or more of alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates are present in a total amount of 0.3 wt% to 5 wt%.
[0044] 10. The material according to clause 9, wherein the material comprises:
[0045] 53 wt % to 60 wt % of acidic and / or neutral cation exchange particles;
[0046] 39 wt % to 44 wt % basic anion exchange particles;
[0047] One or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates are present in a total amount of 0.5 wt% to 3 wt%.
[0048] 11. Material according to clause 7 or clause 8, wherein the material comprises:
[0049] 45 wt % to 59 wt % of acidic and / or neutral cation exchange particles;
[0050] 40 wt % to 54 wt % basic anion exchange particles;
[0051] One or more of alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates are present in a total amount of 0.5 wt% to 5 wt%.
[0052] 12. The material according to clause 11, wherein the material comprises:
[0053] 48 wt % to 56 wt % of acidic and / or neutral cation exchange particles;
[0054] 42 wt % to 50 wt % of basic anion exchange particles;
[0055] One or more of alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates are present in a total amount of 1 wt% to 2 wt%.
[0056] 13. Material according to clause 7 or clause 8, wherein the material comprises:
[0057] 50 wt % to 70 wt % of acidic and / or neutral cation exchange particles;
[0058] 30 wt % to 49 wt % of basic anion exchange particles;
[0059] 0.2 wt% to 3 wt% of one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates, and water-insoluble polymeric ammonium carbonates;
[0060] One or both of Ca(OH)2 and Mg(OH)2 in a total amount of 0.2wt% to 2wt%.
[0061] 14. Material according to clause 13, wherein the material comprises:
[0062] 53 wt % to 67 wt % of acidic and / or neutral cation exchange particles;
[0063] 33 wt % to 46 wt % basic anion exchange particles;
[0064] a total amount of 0.2 wt% to 2 wt% of one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates, and water-insoluble polymeric ammonium carbonates;
[0065] One or both of Ca(OH)2 and Mg(OH)2 in a total amount of 0.2wt% to 1.5wt%.
[0066] 15. A material according to any of the preceding clauses, wherein the material is a material in which:
[0067] The cation exchange particles are acidic and / or neutral water-insoluble metal phosphates;
[0068] The anion exchange particles are basic hydrated zirconium oxide;
[0069] The one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polyammonium carbonates are CaCO3 and / or MgCO3, and optionally, the material further comprises Ca(OH)2.
[0070] 16. A material according to any of the preceding clauses, wherein the material further comprises an organic compound absorbent, wherein the organic compound absorbent accounts for 10wt% to 40wt% relative to the total weight of the components listed in Clause 1, optionally wherein the organic compound absorbent accounts for 15wt% to 25wt%, for example 18wt% to 23wt%, for example 19wt% to 21wt%, relative to the total weight of the components listed in Clause 1.
[0071] 17. The material according to clause 16, wherein the organic compound absorbent is activated carbon.
[0072] 18. A material according to any of the preceding clauses, wherein the material further comprises neutral hydrated zirconium oxide, wherein the neutral hydrated zirconium oxide accounts for 0.1 wt% to 10 wt% relative to the total weight of the components listed in clause 1, optionally wherein the neutral hydrated zirconium oxide accounts for 0.5 wt% to 5 wt% relative to the total weight of the components listed in clause 1.
[0073] 19. A material according to any one of clauses 4 and 5 to 18, wherein as described in clause 4, both acidic zirconium phosphate and neutral zirconium phosphate are present, and the amount of the acidic zirconium phosphate is 55 wt % to 80 wt % of the total amount of zirconium phosphate in the material, and the neutral zirconium phosphate supplies the balance to 100 wt %.
[0074] 20. Material according to clause 19, which:
[0075] (a) the acidic zirconium phosphate accounts for 59 wt% to 70 wt% of the total amount of zirconium phosphate in the material, and the neutral zirconium phosphate provides the balance to 100 wt%; or
[0076] (b) The acidic zirconium phosphate accounts for 75 wt % to 78 wt % of the total amount of zirconium phosphate in the material, and the neutral zirconium phosphate provides the balance to 100 wt %.
[0077] 21. Material according to any of the preceding clauses, wherein:
[0078] (a) mixing all the components together to provide a single layer material; or
[0079] (b) mixing the one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates, and when present, the metal hydroxide, with cation exchange particles to form a first layer and the anion exchange particles to form a second layer.
[0080] 22. A material according to any preceding clause comprising one or both of a water-insoluble alkaline earth metal carbonate and a water-insoluble polymeric ammonium carbonate.
[0081] 23. A kit for adsorption dialysis, comprising the material as described in any one of items 1 to 22. BRIEF DESCRIPTION OF THE DRAWINGS
[0082] Figure 1 : The relationship between the mole fraction of aqueous carbonic acid solution, bicarbonate and carbonate solution and pH.
[0083] Figure 2 : The relationship between the mole fraction of ammonium aqueous solution and ammonia solution and pH.
[0084] Figure 3 : Schematic diagram of an adsorbent box according to an embodiment of the present invention and used in the examples disclosed in the present invention.
[0085] Figure 4 : Experimental setup.
[0086] Figure 5 : Different compositional amounts of Ca(OH)2 and their overall contribution to the dialysate pH profile during a 7-hour treatment period.
[0087] Figure 6 : A sorbent cartridge according to an embodiment of the present invention is depicted. DETAILED DESCRIPTION
[0088] Surprisingly it has been found that the bicarbonate and sodium concentrations in the dialysate for adsorption dialysis can be varied by adding specific metal carbonates and / or specific metal hydroxide salts.
[0089] Therefore, in a first aspect of the present invention, there is provided a material for adsorption dialysis, the material comprising:
[0090] Acidic and / or neutral cation exchange particles;
[0091] Basic anion exchange particles;
[0092] One or more of alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates.
[0093] In certain embodiments, the above-mentioned material may further include one or both of Ca(OH) 2 and Mg(OH) 2 .
[0094] In embodiments of the present invention, the word "comprising" may be interpreted as requiring the features mentioned, but not limiting the presence of other features. Alternatively, the word "comprising" may also refer to a situation where only components / features that are present are listed (for example, the word "comprising" may be replaced by the phrases "consisting of..." or "consisting essentially of..."). It is expressly contemplated that both broader and narrower interpretations may apply to all aspects and embodiments of the present invention. In other words, the word "comprising" and its synonyms may be replaced by the phrases "consisting of..." or the phrases "consisting essentially of..." or their synonyms, and vice versa.
[0095] The phrase "consisting essentially of" and its pseudonyms may be interpreted herein to refer to a material in which small amounts of impurities may be present. For example, the material may be greater than or equal to 90% pure, such as greater than 95% pure, greater than 97% pure, greater than 99% pure, greater than 99.9% pure, greater than 99.99% pure, greater than 99.999% pure, 100% pure.
[0096] As used herein, the term "adsorbent" refers broadly to a class of materials characterized by their ability to absorb a desired substance of interest.
[0097] In the context of this specification, the term "metabolic waste" refers to any component, usually a toxic component, in the dialysate that is produced by metabolism and is desired to be removed during the dialysate detoxification process. Typical metabolic wastes include, but are not limited to, phosphate, urea, creatinine, and uric acid.
[0098] As used herein, the term "essential cations" refers to cations other than sodium ions that are present in the dialysis solution and are essential for its safe and effective use. These ions are typically calcium and magnesium ions, but potassium ions may also be present. Calcium, magnesium, and potassium are removed by the adsorbent and need to be reintroduced into the regenerated dialysate to reconstitute the dialysate.
[0099] The term "cation equivalent" or "total cation equivalent" refers to the sum of all positive charge equivalents in a solution except protons. It is measured in mEq / L.
[0100] As is well known to those skilled in the art, the term "sodium" or the symbol "Na" may be used in the specification to refer to sodium ions rather than the element sodium itself. + ” can be used interchangeably. Likewise, the terms “calcium,” “magnesium,” and “potassium,” or the symbols “Ca,” “Mg,” and “K,” may be used in the specification to refer to calcium ions, magnesium ions, and potassium ions, respectively.
[0101] As used herein, the term "source of spent dialysate" refers to a source of dialysate, regardless of how the dialysate is produced. The source may be any source of waste fluid in which regeneration of a biological fluid occurs by transmembrane exchange. For example, if the dialysis process is hemodialysis, the source of spent dialysate would be the dialyzer in a hemodialysis apparatus. In such an apparatus, the blood flow from the patient and the dialysate are countercurrent, and the exchange occurs across a membrane that separates these flows. Alternatively, it may be the patient, such as in peritoneal dialysis, into which the dialysate is introduced into the patient's peritoneal cavity for exchange.
[0102] As used herein, the term "cation exchange particles" refers to particles that are capable of capturing or immobilizing cations or positively charged species when in contact with the cations or positively charged species, typically by passing a solution of the positively charged species over the surface of the particles.
[0103] As used herein, the term "anion exchange particles" refers to particles that are capable of capturing or immobilizing cations or positively charged species when in contact with anions or negatively charged species, typically by passing a solution of the negatively charged species over the surface of the particles.
[0104] The term "uremic toxin processing enzyme" used in the present invention refers to an enzyme that can react with a uremic toxin as a substrate. For example, a uremic toxin processing enzyme can be an enzyme that can react with urea as a substrate, uric acid as a substrate, or creatinine as a substrate. It can be determined in vitro that the uremic enzyme has this function, for example, by reacting the enzyme with the uremic toxin in a solution and measuring the reduction in the concentration of the uremic toxin. Examples of uremic toxin processing enzymes include, but are not limited to, urease (reacts with urea), urease (reacts with uric acid), or creatininase (reacts with creatinine).
[0105] As is well known to those skilled in the art, the term "uremic toxins" as used herein refers to one or more compounds including waste products, such as decomposition from proteins, nucleic acids, etc. Non-limiting examples of uremic toxins include urea, uric acid, creatinine, and beta-2 (β2) microglobulin. In healthy people, uremic toxins are usually excreted from the body through urine. However, in some populations, uremic toxins cannot be removed from the body at a sufficiently fast rate, resulting in uremic toxicity, i.e., a disease or condition characterized by an increase in the level of at least one uremic toxin relative to the physiological normal level of uremic toxins. Non-limiting examples of conditions associated with uremic toxins include renal disease or dysfunction, gout, and uremic toxicity in subjects receiving chemotherapy.
[0106] The term "uremic toxin handling enzyme particles" as used herein refers to uremic toxin handling enzyme in particle form. The enzyme can be immobilized to a biocompatible solid support by covalent or physical bonds, or by cross-linking, encapsulation or any other means.
[0107] As used herein, the term "soluble source" refers to a compound that is different from the other components of the adsorbent and that can be added to and mixed with the other components, or present as a separate layer or in a compartment separate from the other adsorbent components. It is usually added to the adsorbent in the form of solid particles that are mixed with other solid particles in the adsorbent.
[0108] As used herein, the term "biocompatibility" refers to the property of a material that does not produce an adverse biological response in the human or animal body.
[0109] As used herein, the term "homogeneous" refers to a substantially homogeneous mixture, meaning that the various components of the mixture are in the same proportions throughout a given sample, thereby forming a consistent mixture. The composition of the mixture is generally substantially the same, although it should be understood that when mixing solid particles, there may be areas of incomplete mixing in the sample.
[0110] The term "particle size" refers to the diameter or equivalent diameter of a particle. The term "average particle size" means that most of the particles are close to the specified particle size, although there will be some particles larger than the specified size and some particles smaller than the specified size. The peak in the particle distribution is of the specified size. So, for example, if the average particle size is 50 microns, there will be some larger particles and some particles smaller than 50 microns.
[0111] As used herein, the term "regeneration" or "regenerated" refers to the act of detoxifying the dialysate by destroying and / or absorbing uremic toxins by a sorbent.
[0112] As used herein, the term "regenerated dialysate" refers to dialysate that has been detoxified by the destruction and / or absorption of uremic toxins by sorbents.
[0113] As used herein, the term "reconstitution" or "reconstituted" refers to the act of converting regenerated dialysate to a state and chemical composition substantially identical to fresh dialysate prior to dialysis.
[0114] As used herein, the term "reconstituted dialysate" refers to dialysate that has been converted to substantially the same state and chemical composition as fresh dialysate prior to dialysis.
[0115] The term "predominantly" as used herein is intended to mean a situation or state that occurs mostly or primarily, while not excluding the possibility that other situations or states also occur to a minimal extent. For example, it can be >80% or >90% or >95% or greater than 99%. For the avoidance of doubt, the term covers the possibility of only that situation or state occurring, excluding all other situations or states.
[0116] The word "substantially" does not exclude "completely", for example, a composition "substantially free of" Y may be completely free of Y. If necessary, the word "substantially" may be omitted from the definition of the present invention.
[0117] As used herein, the term "about" in the context of formulation component concentrations generally means ±5% of the stated value, more typically ±4% of the stated value, ±3% of the stated value, ±2% of the stated value, ±1% of the stated value, or even ±0.5% of the stated value.
[0118] In the present invention, certain embodiments may be disclosed in interval format. It should be understood that the description in interval format is only for the purpose of convenience and brevity and should not be interpreted as a rigid limitation on the disclosed interval. Accordingly, the description of the interval should be regarded as having specifically disclosed all possible sub-intervals and the values within the interval. For example, the description of an interval (e.g., from 1 to 6) should be regarded as having specifically disclosed sub-intervals (e.g., from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6, etc.) and single numbers within the interval, such as 1, 2, 3, 4, 5, and 6. This applies regardless of how large the range is.
[0119] Acidic and / or neutral water-insoluble metal phosphates can be any metal phosphate having a solubility in water of no more than 10 mg / L. Examples of suitable acidic and / or neutral water-insoluble metal phosphates include those metal phosphates in which the metal is selected from titanium, zirconium, hafnium and combinations thereof. In specific embodiments that may be mentioned herein, the acidic and / or neutral water-insoluble metal phosphate can be acidic and / or neutral zirconium phosphate. The methods for preparing neutral zirconium phosphate and acidic zirconium phosphate are similar, except that the desired pH value is matched by changing the pH value of the buffer and its ratio relative to sodium zirconium carbonate. The technician can easily determine that both are prepared by mixing sodium zirconium carbonate with a phosphate buffer having a desired pH value in a suitable ratio.
[0120] When used herein, the term "and / or" when applied to two specific materials, such as "acidic and / or neutral zirconium phosphate", is intended to allow for the combination of the above components or the use of the components alone. That is, the term "acidic and / or neutral zirconium phosphate" covers the following embodiments:
[0121] Only acid zirconium phosphate is present;
[0122] Only neutral zirconium phosphate is present; or
[0123] Both acidic and neutral zirconium phosphates exist.
[0124] Acidic and / or neutral water-insoluble metal phosphates can be used as ion exchange materials and are particularly useful as adsorbent materials in regenerative kidney dialysis. For example, zirconium phosphate in sodium or hydrogen form acts as a cation exchanger and absorbs cations such as ammonium (NH4 + ), calcium (Ca 2+ ), potassium (K + ) and magnesium (Mg 2+ In exchange for absorbing these cations, zirconium phosphate releases two other cations, sodium (Na + ) and hydrogen (H + ). When the neutral zirconium phosphate is mixed with the acidic zirconium phosphate, it helps maintain the appropriate pH in situ. Without wishing to be bound by theory, it is believed that the neutral zirconium phosphate helps maintain the bicarbonate balance of the dialysate with CaCO3 and Ca(OH)2.
[0125] In an embodiment, the acidic and / or neutral water-insoluble metal phosphate is configured to exchange ammonium ions mainly for hydrogen ions and to exchange them for sodium ions by setting the essential cations to a low pH during the synthesis process. In order to optimize this property, the cation exchange particles are usually set to a low pH and a low sodium load during the synthesis process. In an embodiment, the cation exchanger is synthesized in the presence of an acid. The pH is adjusted to the desired level, for example, by titrating with a base such as sodium hydroxide to raise the pH to a level that provides the desired poor exchange behavior. Titration is also used to provide enough sodium loading for the cation exchange particles to enable sodium to exchange the desired calcium, magnesium and potassium. In an embodiment, the cation exchange material is zirconium phosphate. This can be synthesized in a conventional process, for example, by basic zirconium sulfate (BZS) or by zirconium carbonate by reacting with phosphoric acid. If other acids are used, a source of phosphate groups must be provided. Typically, by titrating the reaction product with a base, the pH is set in the range of 3.5 to 5.0, preferably about 4.5.
[0126] Acidic zirconium phosphate can also be prepared, for example, by following the method disclosed in U.S. Pat. No. 6,818,196, which is incorporated herein by reference in its entirety. Briefly, acidic zirconium phosphate can be prepared by heating zirconium oxychloride (ZOC) with soda ash to form sodium zirconium carbonate, and treating the sodium zirconium carbonate with caustic soda to form alkaline hydrated zirconium oxide. An aqueous slurry of the alkaline hydrated zirconium oxide can then be heated while phosphoric acid is added. The aqueous slurry of acidic zirconium phosphate can also be titrated with an alkaline reagent such as caustic soda until a desired pH is reached, such as a pH of about 5 to about 7.
[0127] The average particle size of the acidic and / or neutral zirconium phosphate particles can be about 10 microns to about 1000 microns, about 100 microns to about 900 microns, about 200 microns to about 900 microns, about 300 microns to about 800 microns, about 400 microns to about 700 microns, about 500 microns to about 600 microns, about 25 microns to about 200 microns, or about 25 microns to about 150 microns, or about 25 microns to about 80 microns, or about 25 microns to about 50 microns, or about 50 microns to about 100 microns, or about 125 microns to about 200 microns, or about 150 microns to about 200 microns, or about 100 microns to about 175 microns, or about 100 microns to about 150 microns, or about 150 microns to about 500 microns, or about 250 microns to about 1000 microns. The acidic and / or neutral zirconium phosphate particles can be fixed on any known supporting material, which can provide fixing for the zirconium phosphate particles. In one embodiment, the supporting material can be a biocompatible substrate. In one embodiment, the fixation of the acidic and / or neutral zirconium phosphate particles is achieved by physically compacting the particles into a predetermined volume. In one embodiment, the fixation of the acidic and / or neutral zirconium phosphate particles is achieved by sintering the zirconium phosphate or a mixture of zirconium phosphate and a suitable ceramic material. The biocompatible substrate can be a homogeneous substrate made of one material, or a composite substrate composed of at least two materials.
[0128] The anion exchange particles may include amorphous and partially hydrated, water-insoluble metal oxides: hydroxide ions; and / or carbonate ions; and / or acetate ions; and / or anti-lactate ion forms, wherein the metal may be selected from titanium, zirconium, hafnium and combinations thereof. In one embodiment, the metal is zirconium. The anion exchange particles may be zirconium oxide particles. Preferably, the anion exchange particles may be hydrated zirconium oxide particles.
[0129] Basic hydrous zirconium oxide, or NaHZO, refers to a basic form of hydrous zirconium oxide (ZrO(OH)2) in which the zirconium oxide is hydroxylated. NaHZO may have the following chemical and physical properties:
[0130] Composition: Na + x ZrO2(OH - ) y · n H2O
[0131] Ion exchange: ZrO2·OH -
[0132] Among them, Na + x is 1, OH -The y of H2O can be 2 to 4, the n of H2O can be 4 to 6, and x, y and n can be any decimal within these ranges, and can be optionally higher or lower than these ranges. + The content of Na:ZrO2 (molar ratio) may be, for example, in the range of about 0.5:1.5 to about 1.5:0.5, for example, about 1:1, and / or the content of hydroxyl ions may be, for example, in the range of about 3 to about 12 mEq OH - / 10g NaHZO, about 5 to about 10mEq OH - / 10g NaHZO, or about 6 to about 9mEq OH - The pH of NaHZO in water (1 g / 100 mL) can be, for example, about 7 to about 14, about 9 to about 12, or about 10 to about 11. As described in the above formula, the purpose of the basic hydrated zirconium oxide is to release hydroxide ions.
[0133] The average particle size of the basic hydrous zirconium oxide may be from about 10 microns to about 1000 microns, from about 100 microns to about 900 microns, from about 200 microns to about 900 microns, from about 300 microns to about 800 microns, from about 400 microns to about 700 microns, from about 500 microns to about 600 microns, from about 10 microns to about 200 microns, or from about 10 microns to about 100 microns, or from about 10 microns to about 30 microns, or from about 10 microns to about 20 microns, or from about 20 microns to about 50 microns, or from about 25 microns to about 50 microns, or from about 30 microns to about 50 microns, or from about 40 microns to about 150 microns, or from about 80 microns to about 120 microns, or from about 160 microns to about 180 microns, or from about 25 microns to about 250 microns, or from about 250 microns to about 500 microns, or from about 250 microns to about 1000 microns. The zirconium oxide particles may be fixed on any known support material that can provide fixation for the zirconium oxide particles. In one embodiment, the fixation of the zirconium oxide particles may be physical compaction of the particles into a predetermined volume. In one embodiment, the fixation of the zirconium oxide is achieved by sintering the zirconium oxide or a mixture of zirconium oxide and a suitable ceramic material. In one embodiment, the support material is a biocompatible substrate. The biocompatible material may be a carbohydrate-based polymer, an organic polymer, a polyamide, a polyester, a polyacrylate, a polyether, a polyolefin or an inorganic polymer or a ceramic material. The biocompatible substrate may be at least one of cellulose, Eupergit, silica, nylon, polycaprolactone and chitosan.
[0134] In one embodiment, the alkaline hydrated zirconium oxide particles can be replaced with any particles capable of absorbing phosphate ions and other anions. Preferably, the particles are capable of absorbing anions selected from the group consisting of phosphate, fluoride, nitrate and sulfate ions. The zirconium oxide particles can also release ions such as acetate, lactate, bicarbonate and hydroxide in exchange for the absorbed anions.
[0135] Basic hydrated zirconium oxide can be prepared by reacting a zirconium salt (e.g., BZS) or a solution thereof in water with an alkali metal (or alkali metal compound) at ambient temperature to form a precipitate of basic hydrated zirconium oxide. The basic hydrated zirconium oxide particles can be filtered and washed until the anions of the zirconium salt are completely removed and then air dried or dried in an oven at a mild temperature to a moisture level of, for example, about 30 to 40 wt% LOD or less to form a free-flowing powder. Other LODs can be achieved, although achieving lower moisture levels (i.e., LOD of <20 wt%) requires higher temperatures and / or long drying times (e.g., 24-48 hours) to convert zirconium hydroxide bonds to zirconium oxide bonds and reduce the adsorption capacity and basicity of the anion exchange material.
[0136] Basic hydrated zirconium oxide can also be prepared, for example, by following the method disclosed in U.S. Patent Application Publication 2006 / 0140844, which is incorporated herein by reference in its entirety in conjunction with the teachings provided herein. Briefly, this method of preparing basic hydrated zirconium oxide includes adding an aqueous solution of ZOC titrated with concentrated HCl to an aqueous solution of caustic soda. The addition of HCl can prevent excessive gelation during precipitation and promote particle growth. Neutral water and zirconium oxide can be prepared by modifying the procedure described herein for preparing basic zirconium oxide. For example, this can be achieved by controlling the pH of an aqueous slurry formed by treating sodium zirconium carbonate and sodium hydroxide to obtain neutral water and zirconium oxide.
[0137] As mentioned above, the basic components of the adsorbent disclosed herein are water-insoluble alkaline earth metal carbonates, alkali metal carbonates, water-insoluble polymeric ammonium carbonates and combinations thereof. Among the specific embodiments that may be mentioned herein:
[0138] (a) the water-insoluble alkaline earth metal carbonate may be selected from one or more of CaCO3 and MgCO3;
[0139] (b) the alkali metal carbonate may be K2CO3; and / or
[0140] (c) The water-insoluble polymeric ammonium carbonate may be selected from one or more of sevelamer carbonate, polymer-bonded tetraalkylammonium carbonate and 3-(trialkylammonium)alkyl (eg propyl) functionalized silica carbonate.
[0141] When used herein, the term alkyl may refer to a linear or branched C1 to C6 alkyl group, and may include methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, tert-butyl, and the like.
[0142] Without wishing to be bound by theory, it is believed that: water-insoluble alkaline earth metal carbonates; alkali metal carbonates; water-insoluble polymeric ammonium carbonates; and combinations thereof in the adsorbent act as a direct source of bicarbonate and act as a mild pH buffer. Similarly, when Ca(OH)2 and Ca(OH)2 are included in the formulation, they are believed to play a similar role. For example, when CaCO3 (or MgCO3) is present, it acts as a direct source of bicarbonate and acts as a mild pH buffer, while Ca(OH)2 (or Mg(OH)2; when present) is more alkaline and helps to further increase the dialysate pH. High pH facilitates the conversion of CO2 produced during urea hydrolysis or in reaction with ZP into bicarbonate.
[0143] For the above calcium species, the corresponding overall chemical reaction can be presented as shown below,
[0144] CaCO3(s)+H2O(l)+CO2(g)<=>Ca 2+ (aq)+2HCO3 - (aq)
[0145] Ca(OH)2(s)+H2O(l)+2CO2(g)<=>Ca 2+ (aq)+2HCO3 - (aq)
[0146] It will be appreciated that similar reactions will occur when other materials described above are used in place of these calcium species. The conversion to bicarbonate depends on the equilibrium pH, the dissociation constants of CaCO3 and Ca(OH)2, and the dissolution rates.
[0147] In the low urea kit configuration, CaCO3 (or MgCO3) plays a role in regulating HCO3 - balance because in patients with low serum urea, less CO2 is produced by urea hydrolysis. Therefore, conversion to HCO3 - The extra CaCO3 (or MgCO3) acts as a HCO3 - The urea kit is a direct source of urea while helping to adjust the pH and maintain the stability of HCO3 or CO2 already in solution. As used herein, the term "low urea kit configuration" refers to a kit designed to scavenge 3mM to 5.5mM urea concentrations.
[0148] In the high urea kit configuration, Ca(OH)2 plays a role in regulating HCO3 - In the case of treating patients with high serum urea, more CO2 will be present in the dialysate due to the increased amount of urea hydrolyzed.
[0149] Urea + H2O → urease → 2NH3 + CO2
[0150] As used herein, the term "high urea kit configuration" refers to a kit designed for clearing urea concentrations between 5 mM and 8 mM.
[0151] The effect of Ca(OH)2 on the bicarbonate equilibrium is perhaps best shown in Examples 6 and 7, where the addition of 2.5 g of Ca(OH)2 to the sorbent composition resulted in a higher bicarbonate equilibrium than that obtained with the composition of Example 6, where no Ca(OH)2 was present.
[0152] The addition of Ca(OH)2 helps to increase the pH level of the dialysate solution, which aids in the conversion of CO2 to HCO3 - .
[0153] Although Ca(OH)2 and CaCO3 contribute to the total HCO3 - Balance, but adding too much may cause Na + When Ca(OH)2 and CaCO3 are dissolved, Ca2 + Will be released into the dialysate. Ca2 + It will then preferentially bind to zirconium phosphate (or other water-insoluble metal phosphates), taking up some of the ion exchange capacity for sodium and ammonia. Therefore, when designing an optimal adsorbent composition including Ca(OH)2 and CaCO3, factors such as pH, the affinity for Na + Effect of balance, HCO3 - Factors such as equilibrium and ammonium binding capacity.
[0154] In some embodiments of the present invention that may be mentioned herein, the carbonate present in the adsorbent may be an insoluble carbonate. In other words, in some embodiments of the present invention that may be mentioned herein, the material may include one or more water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonate. This can advantageously prevent the carbonate from dissolving rapidly during the dialysis process, ensuring that the adsorbent provides a stable source of bicarbonate throughout the duration of the adsorbent treatment. Therefore, it is believed that the use of water-insoluble carbonates means that the adsorbent is able to provide a stable supply of bicarbonate ions throughout the duration of the dialysis treatment without causing a sharp increase in sodium concentration or pH at the beginning of the treatment.
[0155] Particle size affects the dissolution rate and therefore may be a factor in controlling bicarbonate conversion, sorbent pH, and dialysate pH. This is a design factor that needs to be considered. Any suitable particle size of CaCO3 can be used herein. For example, about 1 μm to about 100 μm. CaCO3 particles with a suitable particle size distribution can be, D90 can be about 38 μm, D50 can be about 16 μm, and D10 can be about 5 μm. Any suitable particle size of Ca(OH)2 can be used herein. For example, about 1 μm to about 80 μm. Ca(OH)2 particles with a suitable particle size distribution can be, D90 can be about 30 μm, D50 can be about 11 μm, and D10 can be about 3 μm.
[0156] Any suitable amount of the above components can be used in the adsorbent disclosed herein. For example, the material can be a material wherein the material comprises:
[0157] 30 wt % to 79 wt % of acidic and / or neutral cation exchange particles;
[0158] 20 wt % to 65 wt % of basic anion exchange particles;
[0159] one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates in an amount of 0.1 wt% to 10 wt% in total;
[0160] One or both of Ca(OH)2 and Mg(OH)2 in a total amount of 0wt% to 5wt%. In a more specific embodiment, it may be a material comprising:
[0161] 30 wt % to 79 wt % of acidic and / or neutral zirconium phosphate;
[0162] 20 wt % to 65 wt % of basic hydrated zirconium oxide;
[0163] 0.1 wt % to 10 wt % of CaCO3 and / or MgCO3;
[0164] 0wt% to 5wt% Ca(OH)2.
[0165] For example, the material may be a material wherein the material comprises:
[0166] 31 wt % to 75 wt % of acidic and / or neutral cation exchange particles;
[0167] 23 wt % to 63 wt % basic anion exchange particles;
[0168] one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates in an amount of 0.1 wt% to 5 wt% in total;
[0169] A total amount of 0wt% to 4wt% of one or both of Ca(OH)2 and Mg(OH)2. In a more specific embodiment, the adsorbent may be a substance comprising:
[0170] 31 wt % to 75 wt % of acidic and / or neutral zirconium phosphate;
[0171] 23 wt % to 63 wt % of basic hydrated zirconium oxide;
[0172] 0.1 wt % to 5 wt % CaCO3 and / or MgCO3;
[0173] 0wt% to 4wt% Ca(OH)2.
[0174] The exact design of the materials disclosed herein can be modified according to the urea concentration expected to be encountered in the dialysate of the subject to be treated. For example, in a subject that may be expected to have low concentrations (e.g., 3 to 5.5 mM) of urea, the material can be a gift wherein the material comprises:
[0175] 50 wt % to 64 wt % of acidic and / or neutral cation exchange particles;
[0176] 35 wt % to 45 wt % of basic anion exchange particles;
[0177] A total amount of 0.3 wt% to 5 wt% of one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polyammonium carbonates. For example, the adsorbent may be a substance comprising:
[0178] 50 wt % to 64 wt % of an acidic or neutral water-insoluble metal phosphate;
[0179] 35 wt % to 45 wt % of basic hydrated zirconium oxide;
[0180] 0.3 wt% to 5 wt% CaCO3 and / or MgCO3.
[0181] For example, the material may be a material wherein the material comprises:
[0182] 53 wt % to 60 wt % of acidic and / or neutral cation exchange particles;
[0183] 39 wt % to 44 wt % basic anion exchange particles;
[0184] A total amount of 0.5 wt% to 3 wt% of one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates. For example, the adsorbent may be a substance comprising:
[0185] 53 wt % to 60 wt % of an acidic or neutral water-insoluble metal phosphate;
[0186] 39 wt % to 44 wt % basic hydrated zirconium oxide;
[0187] 0.5 wt% to 3 wt% CaCO3 and / or MgCO3.
[0188] Alternatively, a suitable material for low urea concentration may be one wherein the material comprises:
[0189] 45 wt % to 59 wt % of acidic and / or neutral cation exchange particles;
[0190] 40 wt % to 54 wt % basic anion exchange particles;
[0191] A total amount of 0.5 wt% to 5 wt% of one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polyammonium carbonates. For example, the adsorbent may be a substance comprising:
[0192] 45 to 59 wt % of an acidic and / or neutral water-insoluble metal phosphate;
[0193] 40 wt % to 54 wt % of basic hydrated zirconium oxide;
[0194] 0.5 wt% to 5 wt% CaCO3 and / or MgCO3.
[0195] For example, the material may be a material wherein the material comprises:
[0196] 48 wt % to 56 wt % of acidic and / or neutral cation exchange particles;
[0197] 42 wt % to 50 wt % of basic anion exchange particles;
[0198] A total amount of 1 wt% to 2 wt% of one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polyammonium carbonates. For example, the adsorbent may be a substance comprising:
[0199] 48 wt % to 56 wt % of an acidic and / or neutral water-insoluble metal phosphate;
[0200] 42 wt % to 50 wt % of basic hydrated zirconium oxide;
[0201] 1 wt% to 2 wt% CaCO3 and / or MgCO3.
[0202] In subjects that may be expected to have high concentrations (e.g., 5 to 8 mM) of urea, the material may be a gift wherein the material comprises:
[0203] 50 wt % to 70 wt % of acidic and / or neutral cation exchange particles;
[0204] 30 wt % to 49 wt % of basic anion exchange particles;
[0205] a total amount of 0.2 wt% to 3 wt% of one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates, and water-insoluble polymeric ammonium carbonates;
[0206] One or both of Ca(OH)2 and Mg(OH)2 in a total amount of 0.2wt% to 2wt%. For example, the adsorbent may be a substance comprising:
[0207] 50 wt % to 70 wt % of an acidic and / or neutral water-insoluble metal phosphate;
[0208] 30 wt % to 49 wt % of basic hydrated zirconium oxide;
[0209] 0.2 wt % to 3 wt % CaCO3 and / or MgCO3;
[0210] 0.2 wt% to 2 wt% Ca(OH)2.
[0211] For example, the material may be a material wherein the material comprises:
[0212] 53 wt % to 67 wt % of acidic and / or neutral cation exchange particles;
[0213] 33 wt % to 46 wt % basic anion exchange particles;
[0214] a total amount of 0.2 wt% to 2 wt% of one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates, and water-insoluble polymeric ammonium carbonates;
[0215] One or both of Ca(OH)2 and Mg(OH)2 in a total amount of 0.2wt% to 1.5wt%. For example, the adsorbent may be a substance comprising:
[0216] 53 wt % to 67 wt % of an acidic and / or neutral water-insoluble metal phosphate;
[0217] 33 wt % to 46 wt % of basic hydrated zirconium oxide;
[0218] 0.2 wt % to 2 wt % CaCO3 and / or MgCO3;
[0219] 0.2wt% to 1.5wt% Ca(OH)2.
[0220] In the above specific embodiments, the acidic and / or neutral water-insoluble metal phosphate may be acidic and / or neutral zirconium phosphate.
[0221] Among the specific embodiments that may be mentioned herein:
[0222] The cation exchange particles are acidic and / or neutral water-insoluble metal phosphates, alkaline hydrated zirconium oxide;
[0223] Anion exchange particles;
[0224] The one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polyammonium carbonates are CaCO3 and / or MgCO3, and optionally, the material further comprises Ca(OH)2.
[0225] The adsorbent may be prepared in any suitable manner. For example, all components may be mixed together to provide a single layer of material. Alternatively, the one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates, and (when present) the metal hydroxide and cation exchange particles may be mixed to form a first layer, and the anion exchange particles form a second layer.
[0226] The above-mentioned materials can further include an organic compound adsorbent. The organic compound absorbent can be mixed with one or more other materials to form a mixed layer, or can form a separate layer. The organic compound absorbent can be selected from activated carbon, molecular sieves, zeolites and diatomaceous earth, etc. The organic compound absorbent particles can be activated carbon particles. In one embodiment, the organic compound absorbent in the base layer can be an activated carbon filter pad. In another embodiment, the organic compound absorbent includes activated carbon particles.
[0227] The activated carbon particles may have an average particle size of from about 10 microns to about 1000 microns, from about 10 microns to about 250 microns, from about 20 microns to about 200 microns, from about 25 microns to about 150 microns, from about 50 microns to about 100 microns, from about 25 microns to about 250 microns, or from about 100 microns to about 200 microns, or from about 100 microns to about 150 microns, or from about 150 microns to about 300 microns, or from about 200 microns to about 300 microns, or from about 400 microns to about 900 microns, or from about 500 microns to about 800 microns, or from about 600 microns to about 700 microns, or from about 250 microns to about 500 microns, or from about 250 microns to about 1000 microns.
[0228] In one embodiment, the activated carbon particles can be replaced by any particles capable of absorbing organic compounds. Preferably, the particles are capable of absorbing organic compounds and / or organic metabolites selected from creatinine, uric acid and other small and medium sized organic molecules without releasing any exchange products. For the purpose of saving space, the activated carbon particles can also be physically compacted into a predetermined volume. In one embodiment, the activated carbon particles are physically compacted into an activated carbon filter pad.
[0229] When an organic compound absorbent is present as part of a material, it may be present in an amount of 10 wt% to 40 wt% relative to the total weight of the components listed in the broadest range of the above-mentioned material (i.e., a material comprising 30 wt% to 79 wt% of acidic and / or neutral zirconium phosphate, 20 wt% to 65 wt% of alkaline hydrated zirconium oxide, 0.1 wt% to 10 wt% of CaCO3 and / or MgCO3, and 0 wt% to 5 wt% of Ca(OH)2). For example, the organic compound absorbent may be present in an amount of 15 wt% to 25 wt%, such as 18 wt% to 23 wt%, such as 19 wt% to 21 wt%, relative to the total weight of the components listed in the broadest range of the above-mentioned material.
[0230] The materials disclosed herein may further include neutral hydrated zirconium oxide, which may be obtained by a method similar to that described herein for producing alkaline hydrated zirconium oxide. When present in the composition described herein, the neutral hydrated zirconium oxide may be present in an amount of 0.1 wt% to 10 wt% relative to the total weight of the components in the broadest range of the above-mentioned materials (i.e., a material comprising 30 wt% to 79 wt% of acidic and / or neutral zirconium phosphate, 20 wt% to 65 wt% of alkaline hydrated zirconium oxide, 0.1 wt% to 10 wt% of CaCO3 and / or MgCO3, and 0 wt% to 5 wt% of Ca(OH)2). For example, the neutral hydrated zirconium oxide may be present in an amount of 0.5 wt% to 5 wt% relative to the total weight of the components listed in the broadest range of the above-mentioned materials.
[0231] Neutral hydrous zirconium oxide may be mixed with one or more other materials to form a mixed layer, or may form a separate layer. For example, it may be mixed with basic hydrous zirconium oxide. Neutral hydrous zirconium oxide may be used as a substitute for basic hydrous zirconium oxide with similar equilibrium results. However, neutral hydrous zirconium oxide may add chloride ions to the patient, so the use of basic hydrous zirconium oxide is preferred over the use of neutral hydrous zirconium oxide. However, an appropriate amount of neutral hydrous zirconium oxide may be added to the adsorbent material.
[0232] In certain embodiments of the present invention, the CaCO 3 and / or MgCO 3 mentioned in the materials described herein may be only CaCO 3 .
[0233] In certain embodiments described herein, the acidic and / or water-insoluble metal phosphate may be an acidic zirconium phosphate. In alternative embodiments, the acidic and / or water-insoluble metal phosphate may be an acidic zirconium phosphate and a neutral zirconium phosphate. Any suitable ratio of acidic and neutral zirconium phosphates may be used herein. Examples of suitable ratios include, but are not limited to, situations where the acidic zirconium phosphate accounts for 55wt% to 80wt% of the total amount of zirconium phosphate in the material, while the neutral zirconium phosphate supplies the balance to 100wt%. For example, the acidic zirconium phosphate may account for 59wt% to 70wt% of the total amount of zirconium phosphate in the material, while the neutral zirconium phosphate supplies the balance to 100wt%; or the acidic zirconium phosphate may account for 75wt% to 78wt% of the total amount of zirconium phosphate in the material, while the neutral zirconium phosphate supplies the balance to 100wt%.
[0234] It should be understood that the components of the materials for adsorption dialysis proposed herein can be provided as separate layers, or can be mixed together in any suitable manner. In a specific embodiment of the invention, all materials can be mixed together to provide a single layer of material. In an alternative embodiment of the invention, CaCO3 and / or MgCO3, and when present, Ca(OH)2 can be mixed with acidic and / or neutral zirconium phosphate to form a first layer, and alkaline hydrated zirconium oxide forms a second layer.
[0235] It is worth noting that problems may arise if CaCO3 and / or MgCO3 and, when present, Ca(OH)2 (and equivalent materials referred to herein, i.e., alkali metal carbonates, water-insoluble alkaline earth metal carbonates, and water-insoluble polyammonium carbonates and Mg(OH)2) are each present as a single homogeneous layer. This is because when these materials are present as a homogeneous layer, a very dense sludge may form resulting in restricted flow through the adsorbent cartridge. Therefore, it is preferred that these materials be mixed with at least one of basic zirconium phosphate and hydrated zirconium oxide (activated carbon or other organic compound absorbent materials may also be mixed when present in the adsorbent).
[0236] It should be understood that the materials disclosed herein can be provided in an adsorbent cartridge and can be arranged accordingly within the adsorbent cartridge to exhibit the intended effects mentioned herein. That is, the materials forming part of the adsorbent can be provided as a single homogenous mixed layer or as two separate layers, as described above.
[0237] Examples of arrangements that may be used include, but are not limited to, Figure 3 and Figure 6 -The arrangement shown in 8.
[0238] Figure 3 A depicts an arrangement in which a sorbent cartridge 300 contains the materials described herein in a single mixed layer 310 sandwiched between a urease layer 320 and an activated carbon layer 330. Each layer is separated from the other layers by filter paper 340.
[0239] Figure 3 b shows a different arrangement, where the material is also mixed with a portion of the urease present in the adsorbent 350 and with a separate urease layer 340 .
[0240] Note that in both arrangements, the dialysate is intended to enter the cartridge at the end proximal to the urease 360 and exit at the end furthest from the urease 370 .
[0241] When used in this article, the term "urease" is a synonym of the term "uremic toxin processing enzyme", and both refer to an enzyme that can react with uremic toxins as a substrate. For example, the uremic toxin processing enzyme can be an enzyme that can react with urea as a substrate, uric acid as a substrate, or creatinine as a substrate. It can be determined in vitro that uremic enzymes have this function, for example, by reacting the enzyme with the uremic toxins in the solution and measuring the reduction of uremic toxin concentrations. The example of uremic toxin processing enzymes includes but is not limited to urease (reacting with urea), urease (reacting with uric acid) or creatininase (reacting with creatinine).
[0242] As is well known to those skilled in the art, the term "uremic toxins" as used herein refers to one or more compounds including waste products, such as decomposition from proteins, nucleic acids, etc. Non-limiting examples of uremic toxins include urea, uric acid, creatinine, and beta-2 (β2) microglobulin. In healthy people, uremic toxins are usually excreted from the body through urine. However, in some populations, uremic toxins cannot be removed from the body at a sufficiently fast rate, resulting in uremic toxicity, i.e., a disease or condition characterized by an increase in the level of at least one uremic toxin relative to the physiological normal level of uremic toxins. Non-limiting examples of conditions associated with uremic toxins include renal disease or dysfunction, gout, and uremic toxicity in subjects receiving chemotherapy.
[0243] The term "uremic toxin handling enzyme particles" as used herein refers to uremic toxin handling enzyme in particle form. The enzyme can be immobilized to a biocompatible solid support by covalent or physical bonds, or by cross-linking, encapsulation or any other means.
[0244] The uremic toxin processing enzyme can be immobilized on any known support material that can provide immobilization for the uremic toxin processing enzyme particles. Immobilization can be performed by physical means, such as by adsorption on alumina. In an embodiment, a non-immobilized enzyme is used. Alternatively, other methods are used to convert urea into ammonia.
[0245] In one embodiment, the support material is a biocompatible substrate to which an enzyme is covalently bound. The biocompatible material can be a carbohydrate-based polymer, an organic polymer, a polyamide, a polyester, or an inorganic polymer or a ceramic material. The biocompatible substrate can be a homogeneous substrate made of one material, or a composite substrate composed of at least two materials. The biocompatible substrate can be at least one of cellulose, Eupergit, silicon dioxide (e.g., silica gel), zirconium phosphate, zirconium oxide, nylon, polycaprolactone, and chitosan.
[0246] In one embodiment, the fixation of uremic toxin treatment enzyme on biocompatible substrate is carried out by fixation technology, and the fixation technology is selected from glutaraldehyde activation, epoxy activation, epichlorohydrin activation, bromoacetic acid activation, cyanogen bromide activation, thiol activation and N-hydroxysuccinimide and diimide amide coupling. The fixation technology used can also be related to the use of silane linker, such as (3-aminopropyl) triethoxysilane, (3-glycidyloxypropyl) trimethoxysilane or (3-mercaptopropyl) trimethylsilane. The surface of biocompatible substrate can be further functionalized with reaction layer and / or stabilizing layer such as dextran or polyethylene glycol and suitable linker and stabilizer molecules such as ethylenediamine, 1,6-diaminohexane, thioglycerol, mercaptoethanol and trehalose. The uremic toxin treatment enzyme can be used in a purified form, or in the form of a crude extract, such as urease extract from Jack Bean or other suitable urease sources.
[0247] The uremic toxin handling enzyme particles may be capable of converting urea to ammonium carbonate. In one embodiment, the uremic toxin handling enzyme is at least one of urease, urease, and creatininase. In a preferred embodiment, the uremic toxin handling enzyme is urease.
[0248] In one embodiment, the uremic toxin handling enzyme particles are urease particles.
[0249] In one embodiment, the average particle size of the uremic toxin handling enzyme can be from about 10 microns to about 1000 microns, from about 100 microns to about 900 microns, from about 200 microns to about 900 microns, from about 300 microns to about 800 microns, from about 400 microns to about 700 microns, from about 500 microns to about 600 microns, or from about 25 microns to about 250 microns, from about 25 microns to about 100 microns, from about 250 microns to about 500 microns, from about 250 microns to about 1000 microns, from about 125 microns to about 200 microns, from about 150 microns to about 200 microns, from about 100 microns to about 175 microns, and from about 100 microns to about 150 microns.
[0250] In one embodiment, 1000 to 10000 units of urease are immobilized on the biocompatible substrate. The total weight of the immobilized urease and substrate ranges from about 0.5 g to about 30 g.
[0251] Figure 6 Another sorbent cartridge 600 according to the present invention is described, wherein CaCO3 and Ca(OH)2 (when present) are mixed together with hydrous zirconium oxide to form a layer 610 (according to the present invention) sandwiched between an activated carbon layer 620 and a zirconium phosphate layer 630. A separate urease layer 640 is also present, and each layer is separated by a filter paper 650. The dialysate is intended to enter via port 660 and exit via port 670 in the cartridge 600.
[0252] 7 depicts another sorbent cartridge 700 according to the present invention, wherein CaCO3 and zirconium phosphate are mixed together to form layer 710, and Ca(OH)2 (when present) is mixed with hydrous zirconium oxide to form layer 720 sandwiched between activated carbon layer 730 and CaCO3 and zirconium phosphate layer 710. There is also a separate urease layer 740, and each layer is separated by filter paper 750. The dialysate is intended to enter via port 760 and exit via port 770 in the cartridge 700.
[0253] FIG8 depicts another sorbent cartridge 800 according to the present invention, wherein CaCO3 and Ca(OH)2 (when present) are mixed together with zirconium phosphate to form a layer 810. This layer is sandwiched between an activated carbon layer 820 and a hydrous zirconium oxide layer 830. There is also a separate urease layer 840, and each layer is separated by a filter paper 850. The dialysate is intended to enter via port 860 and exit via port 870 in the cartridge 800.
[0254] Further embodiments of the invention will now be discussed with reference to the following non-limiting examples.
[0255] Examples
[0256] Materials and methods
[0257] All chemicals used for synthetic dialysate preparation (NaCl, NaHCO3, CaCl2.2H2O, MaCl2.6H2O, KCl, glucose monohydrate, urea, creatinine and NaH2PO4.2H2O) as well as CaCO3 and Ca(OH)2 were purchased from Sigma-Aldrich (USA). Amorphous acidic zirconium phosphate (pH: 3.8-4.3), amorphous neutral zirconium phosphate (pH: 5.8-6.1), amorphous hydrated zirconium oxide (pH: 11.0-11.5) and immobilized urease were prepared as described below. Powdered activated carbon (NDS Centaur) was purchased from Calgon Carbon. All reagents and materials were used without further purification. The pH values of all samples were recorded using a Sartorius PB-10 benchtop pH meter. The concentrations of all analytes (sodium, bicarbonate, urea, ammonia, etc.) were measured using a Vitros-250 chemical analyzer.
[0258] Preparation 1: Preparation of zirconium phosphate
[0259] Zirconium phosphate is synthesized by conventional methods, such as by reaction of an aqueous mixture of basic zirconium sulfate and phosphoric acid, as described in U.S. Pat. No. 3,850,835. Alternatively, it is synthesized from an aqueous mixture of sodium zirconium carbonate and phosphoric acid, as described in U.S. Pat. No. 4,256,718. The product is titrated to a solution pH of 3.8 to 6.1. 5M sodium hydroxide solution is gradually added to the aqueous slurry of zirconium phosphate until the desired pH is reached. After titration, the zirconium phosphate is washed until the filtrate is within acceptable limits for leachables and air dried.
[0260] Preparation 2: Preparation of hydrated zirconium oxide
[0261] The hydrated zirconium oxide is synthesized by conventional methods, for example by reaction of an aqueous mixture of sodium zirconium carbonate and sodium hydroxide, as described in U.S. Pat. No. 4,256,718. This is accomplished by preparing an aqueous slurry of hydrated zirconium carbonate and titrating with 5M sodium hydroxide until the pH of the slurry is 11-12. In some cases, the hydrated zirconium oxide is then washed until the concentration of leachables in the filtrate is within acceptable levels and air dried.
[0262] Example 1
[0263] Preparation of sorbent cartridges
[0264] The adsorbent box consists of the materials listed in Tables 1-3 below. Zirconium phosphate (ZP) was prepared according to Preparation 1. Hydrated zirconium oxide (HZO) was prepared as described in Preparation 2. Immobilized urease (IU) was prepared as described in Examples 1 and 2 of WO 2011 / 102807, the contents of which are incorporated herein by reference. Activated carbon (AC) with a particle size of 50 to 200 microns was used. Calcium carbonate (CaCO3) and calcium hydroxide (Ca(OH)2) were purchased from the market with a particle size range of 1 μm to 100 μm. The adsorbent box used to obtain the following experimental results consists of an empty polypropylene flash tower filled with the above-mentioned adsorbent materials ( Figure 3 ).
[0265]
[0266] Table 1
[0267]
[0268] Table 2
[0269]
[0270] Table 3
[0271] Immobilized urease catalyzes the hydrolysis of urea into ammonia and carbon dioxide. Zirconium phosphate acts as a cation exchanger in the presence of Ca ++ Mg ++ and NH4 + Na is released in the exchange + or H + . Hydrated zirconium oxide acts as an amphoteric ion exchanger, binding primarily negatively charged species such as phosphate and fluoride. The additives CaCO3 and Ca(OH)2 act as sources of carbonate and base and help maintain the pH and bicarbonate balance within the desired range. Activated carbon is a highly microporous material with an extremely high surface area that adsorbs heavy metals, small water-soluble uremic toxins (such as creatinine and uric acid), intermediate molecules (such as B2 microglobulin), and protein-bound uremic toxins. The sorbent cartridge and sorbent material were prepared as described below.
[0272] In the examples used herein, the flash column is filled with:
[0273] 1) Activated carbon layer followed by filter paper separator;
[0274] 2) a mixture of zirconium phosphate, hydrous zirconium oxide, and CaCO3 / Ca(OH)2, followed by a filter paper separator;
[0275] 3) A layer of immobilized urease.
[0276] The flash column was then inverted and installed in the experimental setup so that the spent dialysate first flowed into the immobilized urease layer and was discharged through the activated carbon layer.
[0277] It should be understood that the kits may utilize different mixing and sequencing configurations between layers ( Figure 3 and 7–9).
[0278] General Procedure 1
[0279] Compositions A through H were tested using a proprietary method referred to below as "General Procedure 1". This proprietary method involves pumping two different solutions through the sorbent at a dynamic mixing ratio calculated to more accurately simulate changes in dialysate composition during normal use in vivo. In between, the solution includes a mixture of sugars, salts, toxins (e.g., urea, creatinine, phosphates, and other toxins) mixed in a proprietary ratio. It is believed that the use of a dynamic dialysate solution provides more accurate results than traditional simulated dialysate solutions, thereby enabling more accurate testing of the sorbent.
[0280] The balance of key electrolytes (such as sodium) and bicarbonate is obtained according to the following formula
[0281] Sodium balance = (C Na Drain -C Na pre )*V drain
[0282] Bicarbonate balance = C HCO3 Drain *V drain -C HCO3 SD *V used SD
[0283] In the formula,
[0284] C Na Drain = the sodium concentration C in the liquid collected at the end of the experiment Na pre = average sodium concentration in synthetic dialysate
[0285] V drain = volume of fluid collected at the end of the experiment
[0286] C HCO3 Drain = the concentration of bicarbonate in the fluid collected at the end of the experiment
[0287] C HCO3 SD = Bicarbonate concentration in synthetic dialysate
[0288] Use V SD = Volume of synthetic dialysate containing bicarbonate used in the experiment
[0289] Example 2
[0290] Compositions A, B and C from Example 1 were used in General Procedure 1 with 7.9 to 8.6 mM urea input to produce the results in Table 4.
[0291]
[0292]
[0293] Table 4
[0294] A negative balance means that
[0295] Compositions B and C are "high urea" kits and are prepared by mixing acidic zirconium phosphate and hydrous zirconium oxide in equal proportions with varying amounts of calcium carbonate (composition A is a comparative example and does not contain CaCO3). As shown in Table 4, the desired sodium and bicarbonate balance can be achieved by adjusting the amount of calcium carbonate, with better bicarbonate balance being obtained by increasing the amount of calcium carbonate from 0 g to 3.1 g.
[0296] From the data in Table 4, it can be observed that a continuous increase in the CaCO3 content is accompanied by an increase in the bicarbonate balance, since it acts as a - A source of ionic and sodium balance, calcium preferentially combines with zirconium phosphate, leaving less capacity for other cations.
[0297] Example 3
[0298] Compositions D and E from Example 1 were used in General Procedure 1 with 8.1 mM urea input to produce the results in Table 5.
[0299]
[0300] Table 5
[0301] The amount of ammonia removed was calculated by multiplying the amount of urea removed by 17, and the urea removal rate was calculated by multiplying the difference between the input and output urea concentrations (mmol / 1) by the amount of liquid that had passed through the kit (14 L). The above data show that an increase of 1 g (about 10 mmol) of CaCO3 added to the adsorbent can reduce the ammonia binding by 10 mmol.
[0302] Example 4
[0303] Compositions F, G and G from Example 1 were used in General Procedure 1 with 5.0 to 5.2 mmol / L urea input to produce the results in Table 6.
[0304]
[0305] Table 6
[0306] Compositions FH may be considered to form a "low urea" kit for treating urea loads of 3-5 mmol / L.
[0307] The continuous increase in CaCO3 content is accompanied by an increase in the bicarbonate balance.
[0308] However, due to the lower AZP content, the sodium balance was less affected in this case than in the composition used in Example 2. AZP can adsorb more sodium and ammonium ions because it contains H+ ions, so the reduction in AZP can explain this difference. However, in these compositions, less ammonium ions are released, so the reduction in AZP (compared to that used in Examples 2 and 3) is sufficient to maintain the desired sodium and bicarbonate balance.
[0309] Example 5
[0310] Compositions I and J from Example 1 were used in General Procedure 1 with 2.3 to 5.2 mM urea input to produce the results in Tables 7 and 8.
[0311]
[0312] Table 7
[0313]
[0314] Table 8
[0315] It can be seen that for these "low urea" kits, the sodium balance and bicarbonate balance increase with increasing urea concentration.
[0316] Example 6
[0317] pH curve
[0318] As described above, Examples 2-5 were performed under proprietary conditions. The input dialysate composition was changed to simulate the chemical composition of the dialysate in the peritoneal environment. To this end, the initial dialysate was essentially fresh dialysate at pH 5.2, after which the input dialysate was gradually changed to synthetic spent dialysate at pH 7.4.
[0319] During the experiment, a maximum pH of 7.5 was reached. A mechanism to improve pH was incorporated, the pH level is not without limits. When designing new sorbent configurations, a physiologically acceptable output pH must be between 5 and 8. In addition to considerations regarding metabolic acidosis, low pH levels can lead to increased pCO2 (partial pressure of CO2) levels in the dialysate, which occurs in conjunction with dissolved CO2. Patients exposed to high pCO2 dialysate may experience gas formation in the peritoneum (pneumoperitoneum), which may be the cause of abdominal pain and discomfort.
[0320] The composition of CaCO3 and Ca(OH)2 described in this paper will directly affect the adsorbent in Na + and HCO3 - The final equilibrium performance in terms of balance as well as pH affects the pCO2 level.
[0321] The following additional compositions were prepared and loaded onto the kit according to General Procedure 1 (proprietary method).
[0322] 1. Acidic zirconium phosphate (145.2g) / neutral zirconium phosphate (36.3g) / alkaline hydrated zirconium oxide (148.5) / activated carbon (70g) + Ca(OH)2 (4g)
[0323] 2. Acidic zirconium phosphate (145.2g) / neutral zirconium phosphate (36.3g) / alkaline hydrated zirconium oxide (148.5) / activated carbon (70g) + 4g CaCO3 + 1g Ca(OH)2
[0324] 3. Acidic zirconium phosphate (145.2g) / neutral zirconium phosphate (36.3g) / alkaline hydrated zirconium oxide (148.5) / activated carbon (70g) + 3g CaCO3 + 1.75g Ca(OH)2
[0325] Figure 5 Figure 3 shows the effect of different amounts of Ca(OH)2 on the pH curve during a simulated 14L treatment. As the amount of Ca(OH)2 increased (Experiment 311 vs Experiment 304 / 306), the effect of the pH increase was more prolonged. Since it takes time for urea to diffuse from the blood into the dialysate, it is expected that CO2 produced by urea hydrolysis will increase in the later stages of the dialysis treatment. Therefore, in order to maximize the effect of Ca(OH)2 on HCO3 - The effect of balance is to hopefully also raise the pH in the second half of the treatment.
[0326] General Program 2
[0327] Further experiments were performed using the following procedure, in which synthetic spent dialysate with known electrolyte and toxin concentrations was pumped at a constant flow rate through a cartridge containing the sorbent material ( Figure 4 ).
[0328] Preparation of synthetic dialysate:
[0329] use Figure 4 In the setup shown in , 14 L of synthetic dialysate was used for a single-pass experiment, and the concentrations of various cations and anions in the synthetic dialysate were shown in Table 9. Urea was added according to the desired final urea concentration, which was usually between 3 mMol / L and 8 mMol / L.
[0330] Target value concentration sodium 132 Bicarbonate 20 Lactate 15 calcium 1.25 magnesium 0.25 Potassium 2.7 glucose(%) 1.5 Cl(produced) 101.85
[0331] Table 9
[0332] Synthetic dialysate having the above concentrations was prepared by mixing the salts in the amounts described below in Table 10. The pH of the synthetic dialysate was adjusted to 7.4-7.6 by adding 5N HCl.
[0333]
[0334] Table 10
[0335] Example 7
[0336] Four experiments were performed using the low urea kit under single-pass conditions (General Procedure 2) to demonstrate the effect of input urea concentration and the importance of calcium carbonate in managing bicarbonate and sodium balance. The compositions of the adsorbents tested are shown in Table 11.
[0337] Composition Experiment 1 Experiment 2 Experiment 3 Experiment 4 Acidic zirconium phosphate 129g 129g 129g 129g Neutral zirconium phosphate 57.8g 57.8g 57.8g 57.8g Basic hydrated zirconium oxide 153g 153g 153g 153g Activated carbon 75g 75g 75g 75g <![CDATA[CaCO3]]> 0g 2g 6.5g 6.5g <![CDATA[Ca(OH)2]]> 0g 0g 0g 0g Urea 5.43mM 5.43mM 5.61mM 3.0mM Sodium balance -42.5 -22 9 4.5 Bicarbonate balance -83 -45 -10 -32
[0338] Table 11
[0339] Experiment 1 was performed using the base formulation of the Low Urea Kit (LUC) without calcium carbonate, and a highly negative bicarbonate balance (-83 mmol) was observed since there was no additional source of bicarbonate in the form of calcium carbonate.
[0340] From Experiment 1 to Experiment 3, the amount of calcium carbonate in the sorbent was increased from 0 g (in Experiment 1) to 6 g (in Experiment 3) while maintaining the basic composition of the sorbent and the input dialysate composition. An increase in the average bicarbonate balance from -83 mMol to -10 mMol (column 3) was observed, indicating the importance of calcium carbonate in maintaining a neutral bicarbonate equilibrium. Increasing the amount of calcium carbonate also resulted in a higher sodium balance due to the release of additional sodium ions exchanged for calcium ions contributed by the calcium carbonate.
[0341] Experiment 4 was conducted to demonstrate the effect of input urea concentration on bicarbonate and sodium balances. Experiments 3 and 4 were conducted under similar conditions with the same adsorbent composition. However, the input urea concentration in Experiment 4 was reduced compared to Experiment 3 (5.61 mmol / L vs. 3 mmol / L). A higher sodium balance was observed at higher input urea concentrations due to more ammonium ions (from urea) that could be exchanged with sodium. Higher urea also helped to improve the bicarbonate balance.
[0342] Four additional experiments (Experiment 5 to Experiment 8) were performed using the high urea kit, and the results are shown in Table 12.
[0343] Composition Experiment 5 Experiment 6 Experiment 7 Experiment 8 Acidic zirconium phosphate 146g 146g 146g 146g Neutral zirconium phosphate 41g 41g 41g 41g Basic hydrated zirconium oxide 153g 153g 153g 153g Activated carbon 70g 70g 70g 70g CaCO3 0g 2.0g 2.0g 2.0g <![CDATA[Ca(OH)2]]> 0g 0g 2.5g 2.5g Urea 6.34mM 6.34mM 6.45mM 7.54mM Sodium balance 5.6 13.4 20.1 21.5 Bicarbonate balance -48.9 -29.1 -20.2 -7.6
[0344] Table 12
[0345] It was observed that the trends shown in these results (Experiments 1 to 8 in Example 7) were consistent with the trends in Examples 2 to 5 using the (more accurate) proprietary method.
Claims
1. A material for adsorption dialysis, comprising: Acidic and / or neutral cation exchange particles; Basic anion exchange particles; One or more of alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates.
2. The material according to claim 1, wherein the material further comprises one or both of Ca(OH)2 and Mg(OH)2.
3. A material according to claim 1 or 2, wherein the acidic and / or neutral cation exchange particles are acidic and / or neutral water-insoluble metal phosphates, optionally wherein the metal is selected from one or more of titanium, zirconium and hafnium.
4. The material of claim 3, wherein the metal is zirconium.
5. A material according to any one of the preceding claims, wherein the basic anion exchange particles comprise amorphous and partially hydrated, water-insoluble metal oxides: hydroxide ions; and / or carbonate ions; and / or acetate ions; and / or lactate ion forms, wherein the metal is selected from one or more of titanium, zirconium and hafnium, optionally wherein the anion exchange particles are basic hydrated zirconium oxide.
6. A material according to any one of the preceding claims, wherein: (a) the water-insoluble alkaline earth metal carbonate is selected from one or more of CaCO3 and MgCO3; and / or (b) the alkali metal carbonate is K2CO3; and / or (c) The water-insoluble polymeric ammonium carbonate is selected from one or more of sevelamer carbonate, polymer-bonded tetraalkylammonium carbonate and 3-(trialkylammonium)alkyl functionalized silica carbonate.
7. A material according to any one of the preceding claims, wherein the material comprises: 30 wt % to 79 wt % of acidic and / or neutral cation exchange particles; 20 wt % to 65 wt % of basic anion exchange particles; one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates in an amount of 0.1 wt% to 10 wt% in total; One or both of Ca(OH)2 and Mg(OH)2 in a total amount of 0wt% to 5wt%.
8. The material according to claim 7, wherein the material comprises: 31 wt % to 75 wt % of acidic and / or neutral cation exchange particles; 23 wt % to 63 wt % of basic anion exchange particles; one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates in an amount of 0.1 wt% to 5 wt% in total; One or both of Ca(OH)2 and Mg(OH)2 in a total amount of 0wt% to 4wt%.
9. The material according to claim 7 or 8, wherein the material comprises: 50 wt % to 64 wt % of acidic and / or neutral cation exchange particles; 35 wt % to 45 wt % of basic anion exchange particles; One or more of alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates are present in a total amount of 0.3 wt% to 5 wt%.
10. The material according to claim 9, wherein the material comprises: 53 wt % to 60 wt % of acidic and / or neutral cation exchange particles; 39 wt % to 44 wt % basic anion exchange particles; One or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates are present in a total amount of 0.5 wt% to 3 wt%.
11. The material according to claim 7 or 8, wherein the material comprises: 45 wt % to 59 wt % of acidic and / or neutral cation exchange particles; 40 wt % to 54 wt % basic anion exchange particles; One or more of alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates are present in a total amount of 0.5 wt% to 5 wt%.
12. The material according to claim 11, wherein the material comprises: 48 wt % to 56 wt % of acidic and / or neutral cation exchange particles; 42 wt % to 50 wt % of basic anion exchange particles; One or more of alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates are present in a total amount of 1 wt% to 2 wt%.
13. The material according to claim 7 or 8, wherein the material comprises: 50 wt % to 70 wt % of acidic and / or neutral cation exchange particles; 30 wt % to 49 wt % of basic anion exchange particles; 0.2 wt% to 3 wt% of one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates, and water-insoluble polymeric ammonium carbonates; One or both of Ca(OH)2 and Mg(OH)2 in a total amount of 0.2wt% to 2wt%.
14. The material according to claim 13, wherein the material comprises: 53 wt % to 67 wt % of acidic and / or neutral cation exchange particles; 33 wt % to 46 wt % basic anion exchange particles; a total amount of 0.2 wt% to 2 wt% of one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates, and water-insoluble polymeric ammonium carbonates; One or both of Ca(OH)2 and Mg(OH)2 in a total amount of 0.2wt% to 1.5wt%.
15. A material according to any one of the preceding claims, wherein the material is a material wherein: The cation exchange particles are acidic and / or neutral water-insoluble metal phosphates; The anion exchange particles are basic hydrated zirconium oxide; The one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polyammonium carbonates are CaCO3 and / or MgCO3, and optionally, the material further comprises Ca(OH)2.
16. A material according to any one of the preceding claims, wherein the material further comprises an organic compound adsorbent, wherein the organic compound absorbent accounts for 10wt% to 40wt% relative to the total weight of the components listed in claim 1, optionally wherein the organic compound absorbent accounts for 15wt% to 25wt%, such as 18wt% to 23wt%, such as 19wt% to 21wt%, relative to the total weight of the components listed in claim 1.
17. The material of claim 16, wherein the organic compound absorbent is activated carbon.
18. A material according to any one of the preceding claims, wherein: (a) the material further comprises neutral hydrated zirconium oxide, wherein the neutral hydrated zirconium oxide accounts for 0.1 wt% to 10 wt% relative to the total weight of the components listed in claim 1, optionally wherein the neutral hydrated zirconium oxide accounts for 0.5 wt% to 5 wt% relative to the total weight of the components listed in claim 1; and / or (b)(i) all the components are mixed together to provide a single layer of material; or (ii) mixing the one or more alkali metal carbonates, water-insoluble alkaline earth metal carbonates and water-insoluble polymeric ammonium carbonates, and when present, one or both of Ca(OH)2 and Mg(OH)2 with cation exchange particles to form a first layer, and the anion exchange particles to form a second layer.
19. A material according to any one of claims 4 and 5 to 18, wherein as claimed in claim 4, both acidic zirconium phosphate and neutral zirconium phosphate are present and the amount of acidic zirconium phosphate is 55 wt% to 80 wt% of the total amount of zirconium phosphate in the material, the neutral zirconium phosphate providing the balance to 100 wt%, optionally wherein: (a) the acidic zirconium phosphate accounts for 59 wt% to 70 wt% of the total amount of zirconium phosphate in the material, and the neutral zirconium phosphate provides the balance to 100 wt%; or (b) The acidic zirconium phosphate accounts for 75 wt % to 78 wt % of the total amount of zirconium phosphate in the material, and the neutral zirconium phosphate provides the balance to 100 wt %.
20. A material according to any preceding claim comprising one or both of a water-insoluble alkaline earth metal carbonate and a water-insoluble polymeric ammonium carbonate.
21. A kit for adsorption dialysis, comprising the material according to any one of claims 1 to 20.
Citation Information
Patent Citations
Method to carry out strongly exothermic oxidizing reactions in pseudo-isothermal conditions
US20060140844A1
Method of making granular zirconium hydrous oxide ion exchangers, such as zirconium phosphate and hydrous zirconium oxide, particularly for column use
US3850835A
Sodium zirconium carbonate compound and the method of its preparation
US4256718A
Zirconium phosphate and method of making the same
US6818196B2
A substrate for immobilizing functional substances and method for preparing the same
WO2011102807A1
